Answers are grounded in this paper and cite their sources.
INTRODUCTION: Understanding longitudinal plasma biomarker trajectories relative to brain amyloid changes can help devise Alzheimer's progression assessment strategies. METHODS: C-Pittsburgh compound B (PiB) positron emission tomography (PET) cortical amyloid burden (PiB-/+). Participants (n = 199) were cognitively normal at index visit with a median 6.1-year follow-up. RESULTS: (-1%/year) preceded brain amyloid positivity by 41 years (95% CI = [32, 53]). DISCUSSION: may precede brain amyloid positivity by decades.
No takes yet. Share an insight, caveat, or question.
Bilgel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: